ConductScience.org, home

Paper335960

Clinical and bacteriological evaluation of netilmicin in gram-negative infections.

Klastersky J and 4 others. Antimicrob Agents Chemother, 1977. Cited by 34 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical and bacteriological evaluation of netilmicin in gram-negative infections. Papers, record 335960. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/335960

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical and bacteriological evaluation of netilmicin in gram-negative infections.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
2.38
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klastersky JJ
2Meunier-Carpentier FF
3Coppens-Kahan LL
4Daneau DD
5Prevost JMJ M

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
GentamicinsMajor topic
SisomicinMajor topic
Bacteria
Clinical Trials as Topic
Drug Resistance, Microbial
Humans

Source PubMed

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1836,015In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/836015PubMed
2836,009Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/836009PubMed
3402,104In vitro activity of netilmicin, gentamicin, and amikacin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/402104PubMed
4401,853Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.J Infect Dis1977https://conductscience.org/library/papers/401853PubMed
5319,355Controlled comparison of amikacin and gentamicin.N Engl J Med1977https://conductscience.org/library/papers/319355PubMed
6825,036In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/825036PubMed
7795,373In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/795373PubMed
84,375,433Interaction of purulent material with antibiotics used to treat Pseudomonas infections.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4375433PubMed
94,217,836Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.J Med Microbiol1974https://conductscience.org/library/papers/4217836PubMed
104,596,743Clinical significance of in vitro synergism between antibiotics in gram-negative infections.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4596743PubMed
114,599,859Comparative clinical study of tobramycin and gentamicin.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4599859PubMed
124,810,941Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.J Infect Dis1974https://conductscience.org/library/papers/4810941PubMed
135,002,144Disc plate method of microbiological antibiotic assay. II. Novel procedure offering improved accuracy.Appl Microbiol1971https://conductscience.org/library/papers/5002144PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
7,425,615Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7425615PubMed
6,992,711Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6992711PubMed
2,689,137Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1989https://conductscience.org/library/papers/2689137PubMed
761,144Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.Can Med Assoc J1979https://conductscience.org/library/papers/761144PubMed
666,303Pharmacology and efficacy of netilmicin.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/666303PubMed
426,506Netilmicin in gram-negative bacterial infections.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/426506PubMed
105,797Therapeutic experience with netilmicin.Can Med Assoc J1978https://conductscience.org/library/papers/105797PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/335960

GET https://conductscience.org/api/papers/v1/335960/authors